One-third with common irregular heartbeat don't take blood thinners

January 6, 2017

(HealthDay)—Many people with the heart condition known as atrial fibrillation stop taking the blood-thinning medication that's prescribed to help prevent a stroke, a new study reveals.

Atrial fibrillation is an irregular heartbeat that causes the heart to quiver. This raises the risk of clots and , according to the American Heart Association.

People who've had a medical procedure such as cardioversion (electrical shocks to the heart through electrodes placed on the chest) or ablation (using heat, cold or radio energy to scar heart tissue via catheter or surgery) to help manage their condition were even more likely to ditch their prescribed drugs.

"We don't know if changing the to a normal rhythm, by either cardioversion or ablation, always removes the risk of stroke," said study author Dr. Geoffrey Barnes, a cardiologist at the University of Michigan Frankel Cardiovascular Center.

"It's an ongoing debate, whether to continue the patient on blood thinners after a procedure," Barnes said in a university news release.

The study included more than 700 people with . All had started taking the blood thinner warfarin (brand name Coumadin) between 2011 and 2013.

In less than one year, nearly 37 percent of these people stopped taking the drug, the study found.

The research team also found that more than 54 percent of those who had cardioversion or radiofrequency ablation were off warfarin after one year.

Study participants who didn't have one of these procedures, however, were much more likely to continue warfarin therapy, the study showed. The researchers pointed out that about 30 percent of these people stopped taking the medication, which is still a sizable group not adhering to their treatment plan.

"When we took into account whether the patient had undergone a recent [atrial fibrillation] procedure, the numbers look very different," said Dr. James Froehlich, a study researcher and a Frankel Center cardiologist.

It's unclear why these patients stopped taking warfarin. The researchers speculated the drug's side effects, such as bruising, may play a role. People taking warfarin must also undergo routine blood tests. Some people may stop taking the drug to avoid having to do this, the study authors explained.

"We need to understand why they are stopping warfarin and figure out what other medications might be better adhered to in order to prevent strokes," said Froehlich.

Barnes said more study is needed to learn whether or not are needed to prevent stroke after medical procedures. "We need more data to help us understand what the risk of stroke is after cardioversion or ablation, to inform physician decision-making and guidelines," he said.

Explore further: Medication adherence a problem in atrial fibrillation patients

More information: The American Heart Association provides more information on atrial fibrillation.

Related Stories

Medication adherence a problem in atrial fibrillation patients

January 4, 2017
For patients with atrial fibrillation, the most common form of heart arrhythmia, a main goal of treatment is stroke prevention.

Atrial fibrillation patients are at increased risk of dementia, regardless of anticoagulation use

November 15, 2016
Atrial fibrillation patients who use the drug, warfarin, to prevent harmful blood clots from forming in their hearts to lower risk of stroke are at higher risk of developing dementia than patients who use warfarin for non-atrial ...

Catheter ablations reduce risks of stroke in heart patients with stroke history, study finds

November 13, 2016
Atrial fibrillation patients with a prior history of stroke who undergo catheter ablation to treat the abnormal heart rhythm lower their long-term risk of a recurrent stroke by 50 percent, according to new research from the ...

Trial results for anticoagulants for cardioversion in AF patients published

August 30, 2016
The results of the largest known clinical trial to investigate the use of anticoagulants prior and post cardioversion in atrial fibrillation patients, published in The Lancet, show that non-vitamin K antagonist oral anticoagulants ...

Safer drug combination found for patients with high-risk atrial fibrillation

March 6, 2015
Patients with high-risk atrial fibrillation, or AFib, often require one drug to regulate heart rhythm and a second drug to thin their blood and reduce the risk of stroke. A recent study led by a University of Missouri School ...

Most don't need 'bridging' when they stop warfarin temporarily

August 27, 2015
(HealthDay)—Heart patients on the clot-preventing drug warfarin usually have to stop the medication before having surgery. Now, a new study shows they can safely do that without taking another anti-clotting drug—and they ...

Recommended for you

Biomechanical mapping method aids development of therapies for damaged heart tissue

January 23, 2018
Researchers have developed a new way to capture the detailed biomechanical properties of heart tissue. The high-resolution optical technique fills an important technology gap necessary to develop and test therapies that might ...

Researchers borrow from AIDS playbook to tackle rheumatic heart disease

January 22, 2018
Billions of US taxpayer dollars have been invested in Africa over the past 15 years to improve care for millions suffering from the HIV/AIDS epidemic; yet health systems on the continent continue to struggle. What if the ...

A nanoparticle inhalant for treating heart disease

January 18, 2018
A team of researchers from Italy and Germany has developed a nanoparticle inhalant for treating people suffering from heart disease. In their paper published in the journal Science Translational Medicine, the group describes ...

Starting periods before age of 12 linked to heightened risk of heart disease and stroke

January 15, 2018
Starting periods early—before the age of 12—is linked to a heightened risk of heart disease and stroke in later life, suggests an analysis of data from the UK Biobank study, published online in the journal Heart.

'Decorated' stem cells could offer targeted heart repair

January 10, 2018
Although cardiac stem cell therapy is a promising treatment for heart attack patients, directing the cells to the site of an injury - and getting them to stay there - remains challenging. In a new pilot study using an animal ...

Exercise is good for the heart, high blood pressure is bad—researchers find out why

January 10, 2018
When the heart is put under stress during exercise, it is considered healthy. Yet stress due to high blood pressure is bad for the heart. Why? And is this always the case? Researchers of the German Centre for Cardiovascular ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.